Matsukawa, N <br/><br/>
Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.  [electronic resource] 

 -  Brain research  Jul 2007 
 - 113-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0006-8993 
<br/><br/><label>Standard No.: </label>10.1016/j.brainres.2007.05.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Agents--adverse effects<br/>Animals<br/>Animals, Genetically Modified<br/>Antiparkinson Agents--therapeutic use<br/>Behavior, Animal--drug effects<br/>Disease Models, Animal<br/>Forelimb--drug effects<br/>Gene Expression Regulation--genetics<br/>Gene Transfer Techniques<br/>Genetic Vectors--physiology<br/>Indoles--therapeutic use<br/>Lentivirus--physiology<br/>Male<br/>Medial Forebrain Bundle--drug effects<br/>Motor Activity--drug effects<br/>Oxidopamine--adverse effects<br/>Parkinson Disease--drug therapy<br/>Protein Binding--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D2--genetics<br/>Receptors, Dopamine D3--genetics